Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

175
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

238
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

263
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
263
Obesity01:24

Obesity

1.2K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.2K
Muscles of the Eye01:20

Muscles of the Eye

4.1K
The muscles of the eye are sophisticated structures that control eye movement and focus, allowing for the precise and rapid adjustments necessary for vision. The human eye is controlled by ten muscles — six extraocular muscles, three intraocular muscles, and one primary eyelid retractor muscle.
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and...
4.1K
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

3.5K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiological insights into epiretinal membranes using optical coherence tomography: the Singapore Epidemiology of Eye Diseases Study-2.

The British journal of ophthalmology·2026
Same author

FRZB-induced anti-angiogenic effect via Caveolin-1-mediated TGFβ signalling.

Nature communications·2026
Same author

Real-world outcomes of scleral-fixated intraocular lens: a multi-surgeon study comparing four-point fixation and flanged intrascleral haptic fixation techniques.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025
Same author

The use of electromagnetic transduction therapy in patients with chronic myofascial pain: A pilot double-blinded randomised controlled trial.

Electromagnetic biology and medicine·2025
Same author

Evaluation of a steroid delivery system to mitigate the severity of proliferative vitreoretinopathy in a minipig model.

Frontiers in ophthalmology·2024
Same author

International incidence and temporal trends for rhegmatogenous retinal detachment: A systematic review and meta-analysis.

Survey of ophthalmology·2023

Related Experiment Video

Updated: Jan 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

953

Obesity and eye diseases.

Ning Cheung1, Tien Y Wong

  • 1Centre for Eye Research Australia, University of Melbourne, Victoria, Australia.

Survey of Ophthalmology
|March 16, 2007
PubMed
Summary

Obesity is linked to eye conditions like cataracts and elevated intraocular pressure. However, evidence for links to glaucoma, maculopathy, and diabetic retinopathy is weak, requiring more research on obesity and eye health.

Area of Science:

  • Ophthalmology
  • Public Health
  • Metabolic Disorders

Background:

  • Obesity is a global epidemic with known systemic health impacts.
  • Ocular manifestations of obesity are less understood than its general health effects.
  • Obesity is potentially linked to several eye diseases, including cataracts, glaucoma, age-related maculopathy, and diabetic retinopathy.

Purpose of the Study:

  • To review the current literature on the association between obesity and various ocular conditions.
  • To determine the strength of evidence linking obesity to specific eye diseases.
  • To highlight areas needing further investigation regarding obesity's impact on eye health.

Main Methods:

  • Systematic review of population-based and prospective studies.

More Related Videos

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

953
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.2K
  • Analysis of existing research on obesity and age-related cataract, glaucoma, age-related maculopathy, and diabetic retinopathy.
  • Evaluation of the strength and consistency of reported associations.

    • Main Results:

    • Strong evidence supports an association between obesity and age-related cataract risk.
    • Obesity is linked to elevated intraocular pressure, a risk factor for glaucoma.
    • Inconsistent or insufficient data exists for strong associations between obesity and glaucomatous optic neuropathy, age-related maculopathy, or diabetic retinopathy.

    Conclusions:

    • Obesity may be a risk factor for certain ocular conditions, particularly cataracts and elevated intraocular pressure.
    • Current literature is insufficient to establish convincing links between obesity and glaucoma, age-related maculopathy, or diabetic retinopathy.
    • Further research is needed to clarify obesity's role in eye diseases and whether weight loss mitigates these risks.